Compare ADPT & UPWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADPT | UPWK |
|---|---|---|
| Founded | 2009 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 1.4B |
| IPO Year | 2019 | 2018 |
| Metric | ADPT | UPWK |
|---|---|---|
| Price | $14.54 | $11.07 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 11 |
| Target Price | $17.78 | ★ $22.73 |
| AVG Volume (30 Days) | 2.0M | ★ 3.0M |
| Earning Date | 04-30-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 63.89 | N/A |
| EPS | N/A | ★ 0.84 |
| Revenue | $276,976,000.00 | ★ $787,784,000.00 |
| Revenue This Year | $3.98 | $9.10 |
| Revenue Next Year | $22.72 | $13.60 |
| P/E Ratio | ★ N/A | $13.10 |
| Revenue Growth | ★ 54.77 | 2.40 |
| 52 Week Low | $6.77 | $10.27 |
| 52 Week High | $20.76 | $22.84 |
| Indicator | ADPT | UPWK |
|---|---|---|
| Relative Strength Index (RSI) | 52.25 | 41.70 |
| Support Level | $12.19 | $10.52 |
| Resistance Level | $17.72 | $13.97 |
| Average True Range (ATR) | 0.99 | 0.52 |
| MACD | 0.14 | 0.15 |
| Stochastic Oscillator | 70.42 | 49.54 |
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers. The company has two operating segments: Minimal Residual Disease and Immune Medicine. The company generates the majority of its revenue from the Minimal Residual Disease segment.
Upwork Inc is a United States-based company that operates an online marketplace that enables businesses to find and work with skilled independent professionals. The company develops platform for hiring and freelancing purposes and connects businesses with AI-enabled talent across every on-demand work type, including freelance, agency, fractional, and payrolled. The business generates revenue from Talent and Clients across the USA, India, Pakistan, the Philippines and the rest of the world. Maximum revenue of the company is derived from Talent segment.